Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of intravitreal dexamethasone posterior segment drug delivery system for macular edema after retinal vein occlusion
2004-002502-29Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in Vein occlusion (RVO) and macular edema (3 arms), sponsored by Allergan. Primary endpoints: Best corrected visual acuity and Best corrected visual acuity safety assessment. Started Feb 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
Vein occlusion (RVO)macular edema
Beyond the preview
Go deeper on 2004-002502-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002502-29.